Literature DB >> 32677356

Adult-onset Krabbe disease due to a homozygous GALC mutation without abnormal signals on an MRI in a consanguineous family: A case report.

Zhou Xia1, Yin Wenwen1, Yu Xianfeng1, Hu Panpan1, Zhu Xiaoqun1, Sun Zhongwu1.   

Abstract

BACKGROUND: The most frequent and common form of Krabbe disease (KD) is early-onset KD in infants, and late-onset KD has been reported to be a rare disease. In the present study, we reported an adult-onset KD patient in a consanguineous Chinese family.
METHODS: Clinical and radiological data were collected for a family pedigree. The patient was diagnosed with late-onset KD through next-generation sequencing. The result was confirmed by Sanger sequencing. GALC enzyme activity was also examined by the colorimetry method. Both the grey matter volume (GMV) and white matter volume values were examined and compared with the average values from ten age-matched normal controls. Moreover, we reviewed all the available KD studies on PubMed to understand the correlation between the phenotype and genotype of the identified mutation.
RESULTS: The main manifestations of the proband were sudden onset seizures and cognitive decline. Mutation analysis of the GALC revealed a homozygous c.1901T>C mutation in exon 16, which resulted in an amino acid change in p.L634S. Sanger sequencing results showed that the homozygous mutation was inherited from the patient's parents, both of whom were revealed to be heterozygous carriers. Moreover, a decrease in GALC enzyme activity was also detected. However, no abnormal signals were found in the brain MRI. Further structural MRI analysis revealed a significantly decreased GMV in the proband compared to the normal controls. Moreover, it is of interest that all patients with the c.1901T>C mutation had late-onset KD and were selected from Asian countries, especially Japan and China.
CONCLUSIONS: This patient with a homozygous GALC mutation expands the clinical presentation and characteristics of adult-onset KD, as indicated by grey matter atrophy without abnormal white matter signals.
© 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.

Entities:  

Keywords:  zzm321990GALCzzm321990; Krabbe disease; grey matter atrophy

Mesh:

Substances:

Year:  2020        PMID: 32677356      PMCID: PMC7507702          DOI: 10.1002/mgg3.1407

Source DB:  PubMed          Journal:  Mol Genet Genomic Med        ISSN: 2324-9269            Impact factor:   2.183


INTRODUCTION

Krabbe disease (KD), or globoid cell leukodystrophy (OMIM #245200), is a rare inherited autosomal recessive lysosomal storage disorder caused by galactocerebrosidase (GALC) gene mutations (Suzuki & Suzuki, 1970). GALC mutations lead to defective functions of the GALC enzyme, resulting in demyelination of both the central and peripheral nervous systems. Based on the age of onset, KD is usually categorized as early‐onset KD (infantile form: <6 months) and late‐onset KD. The latter type includes a spectrum of late infantile‐onset (7 months to 2 years), juvenile‐onset (3‐8 years) and adult‐onset (>9 years) onset KD (Xu, Sakai, Taniike, Inui, & Ozono, 2006). The late‐onset forms of KD are rare and are clinically more heterogeneous, with signs that vary from hemiparesis, cerebellar ataxia, and seizures to progressive motor impairment, mental retardation, and behaviour changes; however, this form progresses more slowly than the early‐onset form (Sakai & Otomo, 2016; Yang et al., 2013). The diagnosis of KD is made by measuring GALC enzyme activity and identifying the presence of theGALC mutations (Adachi et al., 2016; Madsen et al., 2019). The typical imaging feature of KD is involvement of the corticospinal tracts or periventricular white matter (Cousyn et al., 2019). In the present report, we describe an adult‐onset KD patient without abnormal signals on an MRI in a consanguineous Chinese family with a homozygous mutation discovered by next‐generation sequencing (NGS), and we summarized all studies of the same gene mutations (Furuya et al., 1997; Hossain et al., 2014; Lim et al., 2016; Satoh et al., 1997; Xu et al., 2006; Yoshimura, Kibe, Irahara, Sakai, & Yokochi, 2016; Zhang et al., 2018; Zhao et al., 2018).

CLINICAL REPORT

A 22‐year‐old Chinese woman was referred to our hospital for further neurologic evaluation of neurological symptoms that included psychotic symptoms, such as forced weeping and laughing, and cognitive impairment. She had been repeatedly in and out of another local hospital one‐month prior because of several episodes of generalized convulsions. Her growth and development had been normal until the age of 13 years, and she had begun to feel excessively fatigued after exercise. On admission, a general physical examination showed no abnormalities. In the neurologic examination, she was alert, oriented, and cooperative. A neuropsychological battery that included the Mini‐Mental State Examination (MMSE), the Cambridge Cognitive Examination‐Chinese version (Camcog‐C), the Hamilton Anxiety Scale (HAMA) and the Hamilton Depression Scale (HAMD), was performed to evaluate her cognition and emotion status. She presented MMSE 23/30, Camcog‐C 66/108 (praxis 5), HAMA 8, HAMD 12, which indicated a decrease in global cognition, especially in executive function and slight depression. Cranial nerves, muscle strength, finger‐to‐nose tests and sensation were normal. Bilateral pathological reflexes were negative. There were no sensory deficits. Routine laboratory examinations of blood and urine were normal. Other items that were examined for a differential diagnosis, such as serum levels of folic acid, vitamin B12, total homocysteine, lactic acid, endocrinologic items, oligoclonal bands, and autoimmune encephalitis antibodies in the cerebrospinal fluid were also in the normal range. The motor nerve conduction velocity results were in the reference range. The sensory nerve conduction velocity was 34.9 m/s on the left side and 35.2 m/s on the right side of the peroneal nerve and 36.5 m/s on the left side and 35.7 m/s on the right side of the tibial nerve, suggesting the presence of sensory neuropathy. An electroencephalogram (EEG) test presented no epileptic discharge. Evoked potentials, including auditory evoked responses, visual evoked potentials, and somatosensory evoked potentials, were unremarkable.

METHODS AND RESULTS

Ethical compliance

The Institutional Review Board of the First Affiliated Hospital of Anhui Medical University Subcommittee on Human Studies approved this study, and the approval number is Quick‐PJ 2020‐01‐12. Informed written consent was obtained from the patient's family and the volunteers for this study.

MRI findings

MRI results showed mild brain atrophy but no significant hyperintensities in the white matter on the T2‐weighted and fluid‐attenuated inversion recovery (FLAIR) images (Figures 1 and 2). Brain atrophy was evaluated by a previously established clinical rating method (Besteher et al., 2017; Victoroff, Mack, Grafton, Schreiber, & Chui, 1994). Both of the patient's parents presented no abnormal signals on brain MRI. To obtain accurate grey matter values, ten normal controls were recruited for this study by advertisements (age: 23.2 ± 1.03 years (20–24)). Voxel‐based morphometry (VBM) analysis results showed that the grey matter value of the patient (502 mm3) was more than two standard deviations (SDs) beyond that of the controls (667 ± 71.27 mm3). We also found a tendency toward decreased white matter volume in the patient, although the differences did not reach 2 SDs (415 mm3 vs. 547.5 ± 75.36 mm3).
Figure 1

Standard T1 axial images of different severities of frontal lobe atrophy: (a) none; (b) mild; (c) severe; and (d) the mild brain atrophy of the proband according to the standard image

Figure 2

T2‐weighted magnetic resonance imaging (MRI), and axial fluid‐attenuated inversion recovery (FLAIR) imaging showed no abnormal signals in the proband

Standard T1 axial images of different severities of frontal lobe atrophy: (a) none; (b) mild; (c) severe; and (d) the mild brain atrophy of the proband according to the standard image T2‐weighted magnetic resonance imaging (MRI), and axial fluid‐attenuated inversion recovery (FLAIR) imaging showed no abnormal signals in the proband

Mutation analysis and GALC enzyme activity test

The molecular analysis of the GALC (reference mRNA sequence: NM_000153.3) was performed by next‐generation sequencing (NGS) technology and revealed that the patient had a homozygous point mutation of c.1901T>C in exon 16 (Figure 3). This mutation results in a single amino acid substitution at position 634 from leucine to serine (Leu634Ser). Sanger sequencing results showed that the homozygous mutations were inherited from the patient's parents, both of whom were revealed as heterozygous carriers (Figure 2).
Figure 3

Molecular genetic analysis of the GALC (Reference mRNA sequence: NM_000153.3) showed the c.1901T>C, p.L634S mutation; this patient (a) was homozygous for this mutation, and her father (b) and mother (c) were heterozygous. The proband is indicated by an arrow in the pedigree chart of the family. M: 1901T>C: p.L634S, N: normal

Molecular genetic analysis of the GALC (Reference mRNA sequence: NM_000153.3) showed the c.1901T>C, p.L634S mutation; this patient (a) was homozygous for this mutation, and her father (b) and mother (c) were heterozygous. The proband is indicated by an arrow in the pedigree chart of the family. M: 1901T>C: p.L634S, N: normal The results for patient with the c.1901T>C mutation are shown in Table 1. The GALC activity of the 18 patients included in the available studies was consistently decreased in the lymphocytes, the skin or both. All patients had late‐onset KD. It is of interest that all 18 patients were from Asian countries, especially Japan and China. The clinical manifestations mainly included spastic paraparesis, gait disturbance, mental deterioration, hearing and vision impairments and language problems. The typical imaging features in the reported studies were predominant corticospinal tract involvement.
Table 1

Summary of clinical information and mutations identified in KD patients with p.L634S (p.L618S) mutation in previous case reports

No.Age at onsetPhenotypeGenotypeClinical symptomsa Brain MRIa CountryAbnormal GALC activitya Author, years of publication
151 yAdultp.[L618S]; [L618S]Slowly progressive spastic paraparesis and diminished vibration senseBilateral frontoparietal subcortical white matter and centrum semiovaleJapanLYM+SFSatoh et al. (1997)
210–20 yAdultp.[L618S]; [IVS6 + 5G‐A]Spastic gait, mental deteriorationSelective pyramidal tractJapanLYMFuruya et al. (1997)
38 mLate‐infantilep.[P302A]; [L618S]NNJapanLYM+SFXu et al. (2006)
411 mLate‐infantilec.[1719dupT]; p.[L618S]NNJapanLYMHossain et al. (2014)
51 y and 2 mLate‐infantilec.[1719dupT]; p.[L618S]NNJapanLYMHossain et al. (2014)
62 yLate‐infantilep.[L618S]; [?]NNJapanLYMHossain et al. (2014)
73 yJuvenilep.[P302A]; [L618S]NNJapanSFHossain et al. (2014)
814 yAdultp.[L618S]; [?]NNJapanLYMHossain et al. (2014)
935 yAdultp.[L618S]; [G646A]NNJapanSFHossain et al. (2014)
1056 yAdultp.[L618S]; [?]NNJapanLYMHossain et al. (2014)
1111 mLate‐infantilec.635_646 delinsCTC, [p.L618S]Developmental regression and spastic paraparesisPredominantly the corticospinal tractJapanLYM+SFYoshimura et al. (2016)
1212 yAdultc.[1687A<T];[1901T>C]Slow, progressive spastic gait disturbancePrecentral motor cortex, corona radiata, posterior limb of the internal capsule, cerebral peduncle of the bilateral pyramidal tracts and optic radiationKoreaLYMLim et al. (2016)
1310 mLate‐infantilep. [F350 V]; [L618S]Motor regression, language development delay, hearing and vision impairmentNChinaLYMZhao et al. (2018)
142 yLate‐infantilep.[R129X]; [L618S]Motor regressionNChinaLYMZhao et al. (2018)
158 y and 10 mJuvenilec.[195+1G>A]; p.[L618S]Loss of vision, unstable walkingNChinaLYMZhao et al. (2018)
16<5 yJuvenilep. [P318 L]; [L618S]Left limb movement disorderNChinaLYMZhao et al. (2018)
1720 yAdultp.[L618S]; [?]Psychomotor regressionNChinaLYMZhao et al. (2018)
1820 yAdultc.1901T>C : c.1901delTAphasiaSelective pyramidal tractChinaLYMZhang et al. (2018)

a GALC activity is measured in lymphocytes and skin fibroblasts, respectively. LYM: lymphocyte; SF: skin fibroblast. N: not given in the studies

Summary of clinical information and mutations identified in KD patients with p.L634S (p.L618S) mutation in previous case reports a GALC activity is measured in lymphocytes and skin fibroblasts, respectively. LYM: lymphocyte; SF: skin fibroblast. N: not given in the studies In the patient in this case,GALC enzyme activity level was decreased at 3.3 nmol/17 h/mg (>12.7 nmol/17 h/mg) according to colorimetry performed with a SPECTRA MAX GEMINI XPS fluorescent enzyme labelling instrument. Both the patient's father and mother showed normal GALC activity levels (123.5 nmol/17 h/mg and 56.93 nmol/17 h/mg, respectively).

DISCUSSION

To the best of our knowledge, this is the first report to describe the phenotype of adult‐onset KD associated with the homozygous mutation c.1901T>G (p.Leu618Ser) in China and is also the second reported case of a homozygous mutation (c.1901T>G). There is only one previously published report; it describes a Japanese adult‐onset KD patient, and was initially reported in 1997. Moreover, grey matter atrophy, especially in the frontal lobe, seemed to be the unique change in the MRI of this patient, which is different from previous studies, in which the patients presented with selective pyramidal tract impairment. The mutation located at c.1901T>G has previously been reported and is considered to be predominantly related to late‐onset KD (Zhang et al., 2018). In the current report, the patient was 13 years old when she began experiencing a slow gait, which is a symptom of adult‐onset KD. When the data for all the patients with the c.1901T>G mutation were summarized, the age of onset was found to range from 8 months to 51 years. These observations, combined with our report, indicate that the c.1901T>G mutation may selectively exist in patients with late‐onset KD. In previous studies, the c.1901T>G mutation was also regarded as a mild mutation type due to its slight symptoms, which include gait disturbance, cognitive impairment, peripheral disease, vision loss, and so on (Satoh et al., 1997; Zhang et al., 2018). Notably, the present patient exhibited most of these clinical symptoms but with insidious onset and slow progress, further supporting the possibility that the c.1901T>G mutation contributes to a more benign clinical outcome than infantile early‐onset KD. Moreover, it was also observed that the c.1901T>G mutation was found only in Asian countries; in contrast, Caucasian patients primarily have a 30‐kb deletion mutation (Hossain et al., 2014). This result raises the possibility that the KD mutation has a regional tendency. Therefore, this summary, along with our case study may aid in elucidating and extending the genotype‐phenotype correlation of mutations in KD. Selective demyelinating lesions involving the corticospinal tracts or periventricular white matter are the usual imaging characteristics. Myelin impairment in KD largely includes increases in globoid cells and macrophages and proliferating astrocytes, according to the post‐mortem findings. However, in our report, no significant white matter hyperintensities (WMHs) were found on the MRI, and the patient had only slight brain atrophy, especially in the frontal lobe. To the best of our knowledge, there have been no previous reports of imaging findings with grey matter atrophy as a unique characteristic in this disease. Only one report of an adult‐onset KD patient described a normal brain MRI, suggesting that these clinical symptoms may precede imaging changes (Bajaj, Waldman, Orrell, Wood, & Bhatia, 2002). However, in previous studies, some KD patients' symptoms were accompanied by grey matter atrophy in the late phases along with typical abnormal signals on MRIs (Wang, Melberg, Weis, Månsson, & Raininko, 2007). The pathogenetic basis of this finding is unknown and requires further study. It is suspected that brain atrophy is the prophase of KD, while typical WMHs may be found in subsequent years. In the current study, we also found that there was a decreasing trend in white matter atrophy, although the differences were not two SDs greater than those of the controls, which may provide insight for further speculation. It has been suggested that brain volume may be associated with cognition (Marino et al., 2019). Therefore, the cognitive impairment of the proband may be attributed to the decreased grey matter and white matter volume. Specifically, frontal lobe atrophy not only contributed to the symptoms of forced weeping and laughing but also to the praxis deficit. These clinical and brain structural features were different from those of the only reported case of a homozygous mutation (c.1901T>G) in adults. We thus claim that searching for subtle changes in MRIs will improve the ability to diagnose KD earlier, especially when structural MRIs based on the CAT method are used to accurately assess the brain when there is only slight brain atrophy. Clinical variabilities, especially in MRIs, have been referred to in previous studies and these were partly explained by the differences in the activation of enzyme systems that control the level of galactosylsphingosine (Barone et al., 1996). However, the exact pathogenesis mechanism is still beyond our understanding, and this needs to be further explored in future case studies. This case report and summary demonstrated that the c.1901T>G mutation preferentially existed in patients in Asian countries and selectively involved mild forms of late‐onset KD. The atypical MRI presentation with of brain atrophy in KD in our report expanded the possible phenotypes by providing a clinical presentation. The early diagnosis and management of patients with KD may lead to improved outcomes. Further clinical and neuroradiological studies could be helpful in providing insights into the pathogenesis of the disorder.

CONFLICT OF INTEREST

The authors declare that they have no conflicts of interest.

AUTHOR CONTRIBUTIONS

Zhou Xia, Yin Wenwen, Yu Xianfeng, Hu Panpan, Zhu Xiaoqun, and Sun Zhongwu clinically characterized the patient. Zhou Xia and Yin Wenwen performed the experiments. Zhou Xia and Sun Zhongwu planned and supervised the study, wrote the article and provided the funding. All authors approved the final version of the manuscript.
  21 in total

Review 1.  Adult-onset Krabbe disease with homozygous T1853C mutation in the galactocerebrosidase gene. Unusual MRI findings of corticospinal tract demyelination.

Authors:  J I Satoh; H Tokumoto; K Kurohara; M Yukitake; M Matsui; Y Kuroda; T Yamamoto; H Furuya; N Shinnoh; T Kobayashi; Y Kukita; K Hayashi
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

2.  Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.

Authors:  Mohammad Arif Hossain; Takanobu Otomo; Seiji Saito; Kazuki Ohno; Hitoshi Sakuraba; Yusuke Hamada; Keiichi Ozono; Norio Sakai
Journal:  Gene       Date:  2013-11-16       Impact factor: 3.688

3.  Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation.

Authors:  Chengzhe Xu; Norio Sakai; Masako Taniike; Koji Inui; Keiichi Ozono
Journal:  J Hum Genet       Date:  2006-04-11       Impact factor: 3.172

4.  Brain MRI features and scoring of leukodystrophy in adult-onset Krabbe disease.

Authors:  Louis Cousyn; Bruno Law-Ye; Nadya Pyatigorskaya; Rabab Debs; Roseline Froissart; Monique Piraud; Antonio Federico; Simona Salvatore; Alfonso Cerase; Maria C Macário; João Durães; Seung H Kim; Hiroshi Adachi; Bertrand Audoin; Xavier Ayrignac; Yuwei Da; Robert Henderson; Roberta La Piana; Cornelia Laule; Kiyotaka Nakamagoe; Raili Raininko; Ludger Schols; Sandra M Sirrs; Fausto Viader; Karol Jastrzębski; Delphine Leclercq; Yann Nadjar
Journal:  Neurology       Date:  2019-07-23       Impact factor: 9.910

5.  Familial adult onset of Krabbe's disease resembling hereditary spastic paraplegia with normal neuroimaging.

Authors:  N P S Bajaj; A Waldman; R Orrell; N W Wood; K P Bhatia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

6.  Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase.

Authors:  K Suzuki; Y Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

7.  Four novel GALC gene mutations in two Chinese patients with Krabbe disease.

Authors:  Yao Yang; Xiaotun Ren; Quangang Xu; Chunzhi Wang; Haihong Liu; Xiyu He
Journal:  Gene       Date:  2013-02-24       Impact factor: 3.688

8.  Adult-onset Krabbe disease in two generations of a Chinese family.

Authors:  Tongxia Zhang; Chuanzhu Yan; Kunqian Ji; Pengfei Lin; Lingyi Chi; Xiuhe Zhao; Yuying Zhao
Journal:  Ann Transl Med       Date:  2018-05

9.  Predominant Corticospinal Tract Involvement in a Late Infant with Krabbe Disease.

Authors:  Ayumi Yoshimura; Tetsuya Kibe; Kaori Irahara; Norio Sakai; Kenji Yokochi
Journal:  Jpn Clin Med       Date:  2016-09-18

10.  Longitudinal analysis of brain atrophy in Alzheimer's disease and frontotemporal dementia.

Authors:  Silvia Marino; Lilla Bonanno; Viviana Lo Buono; Rosella Ciurleo; Francesco Corallo; Rosa Morabito; Gaetano Chirico; Angela Marra; Placido Bramanti
Journal:  J Int Med Res       Date:  2019-09-16       Impact factor: 1.671

View more
  5 in total

1.  CRISPR-Cas9 Knock-In of T513M and G41S Mutations in the Murine β-Galactosyl-Ceramidase Gene Re-capitulates Early-Onset and Adult-Onset Forms of Krabbe Disease.

Authors:  Rima Rebiai; Emily Rue; Steve Zaldua; Duc Nguyen; Giuseppe Scesa; Martin Jastrzebski; Robert Foster; Bin Wang; Xuntian Jiang; Leon Tai; Scott T Brady; Richard van Breemen; Maria I Givogri; Mark S Sands; Ernesto R Bongarzone
Journal:  Front Mol Neurosci       Date:  2022-05-10       Impact factor: 6.261

2.  Comprehensive analysis of recessive carrier status using exome and genome sequencing data in 1543 Southern Chinese.

Authors:  Jeffrey Fong Ting Chau; Mullin Ho Chung Yu; Martin Man Chun Chui; Cyrus Chun Wing Yeung; Aaron Wing Cheung Kwok; Xuehan Zhuang; Ryan Lee; Jasmine Lee Fong Fung; Mianne Lee; Christopher Chun Yu Mak; Nicole Ying Ting Ng; Claudia Ching Yan Chung; Marcus Chun Yin Chan; Mandy Ho Yin Tsang; Joshua Chun Ki Chan; Kelvin Yuen Kwong Chan; Anita Sik Yau Kan; Patrick Ho Yu Chung; Wanling Yang; So Lun Lee; Godfrey Chi Fung Chan; Paul Kwong Hang Tam; Yu Lung Lau; Kit San Yeung; Brian Hon Yin Chung; Clara Sze Man Tang
Journal:  NPJ Genom Med       Date:  2022-03-21       Impact factor: 8.617

Review 3.  A neglected neurodegenerative disease: Adult-onset globoid cell leukodystrophy.

Authors:  Guode Wu; Zhenhua Li; Jing Li; Xin Li; Manxia Wang; Jing Zhang; Guangyao Liu; Pengfei Zhang
Journal:  Front Neurosci       Date:  2022-09-07       Impact factor: 5.152

4.  Pathogenic Variants in GALC Gene Correlate With Late Onset Krabbe Disease and Vision Loss: Case Series and Review of Literature.

Authors:  Nicholas A Bascou; Maria L Beltran-Quintero; Maria L Escolar
Journal:  Front Neurol       Date:  2020-10-15       Impact factor: 4.003

5.  Adult-onset Krabbe disease due to a homozygous GALC mutation without abnormal signals on an MRI in a consanguineous family: A case report.

Authors:  Zhou Xia; Yin Wenwen; Yu Xianfeng; Hu Panpan; Zhu Xiaoqun; Sun Zhongwu
Journal:  Mol Genet Genomic Med       Date:  2020-07-17       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.